EMD SERONO, INC. for EMD SERONO INC
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Science/Technology SCI
P.L. 117-167: Supreme Court Security Funding Act of 2022 (H.R. 4346 -CHIPS and Science Act of 2022) - discussions related to ensuring program functionality
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| DAVID NICHOLS | — |
Trade (domestic/foreign) TRD
Discussions related to tariffs
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| DAVID NICHOLS | — |
Health Issues HCR
H.R. 2214: DRUG Act ; all provisions S. 864: HELP Copays Act; all provisions S. 882: Patients Before Middlemen Act; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX Executive Order: Expanding Access to In Vitro Fertilization; all provisions of the order General discussions related to Pharmacy Benefit Manager policy issues General discussions related to Healthcare supply chain policy issues General discussions related to Drug cost and pricing policy issues General discussions related to caregiving support and awareness policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Medicare/Medicaid MMM
H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.; all provisions S. 832: EPIC Act of 2025; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX General discussions related to Drug cost and pricing policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Pharmacy PHA
General discussions related to Drug cost and pricing policy issues General discussions related to Healthcare supply chain policy issues General discussions related to 340B Drug Pricing Program policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Taxation/Internal Revenue Code TAX
Discussions regarding 2025 Tax Reform efforts related to Research & Development (R & D) Tax Amortization, Base Erosion and Anti-Abuse Tax (BEAT), and Foreign Derived Intangible Income Tax (FDII)
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| DAVID NICHOLS | — |
Veterans VET
Discussions related to Veteran access to infertility care
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Defense DEF
Discussions related to Military access to infertility care
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Copyright/Patent/Trademark CPT
General discussions related to Biopharmaceutical innovation and patent policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Labor Issues/Antitrust/Workplace LBR
Discussions related to H1B Visas grace period
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| DAVID NICHOLS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.